Cytogenetic abnormalities in uveal melanoma based on tumor features and size in 1059 patients: The 2016 W
Los agonistas GLP-1 aprobados por la FDA incluyen semaglutida inyectable (Ozempic para diabetes, Wegovy para control de peso), semaglutida oral (Rybelsus para diabetes), dulaglutida (Trulicity), liraglutida (Victoza para diabetes, Saxenda para control de peso) y exenatida (Bydureon BCise)
Serious but rare adverse effects include pancreatitis, hypoglycaemia when combined with insulin or sulfonylureas, and gallbladder problems
Cuddapah VA, Zhang LS, Sehgal A (2019) Regulation of the blood-brain barrier by circadian rhythms and sleep
Thus, long-term disease management requires diagnostic and monitoring approaches that are safe and acceptable for repeated use